Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of September 2022. The document serves as a transaction notification regarding a purchase of company securities by a Person Discharging Managerial Responsibilities (PDMR).
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It is strictly a regulatory disclosure of a specific share transaction.
Material Changes
The filing reports a single transaction executed on September 29, 2022:
- Insider: Sir Jonathan Symonds (Non-Executive Chairman).
- Transaction Type: Purchase.
- Instrument: 3,220 Ordinary Shares of 31 1/2 pence each (ISIN: GB00BN7SWP63).
- Price: £13.2433 per share.
- Location: London Stock Exchange (XLON).
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, risk factors, contingencies, or details on unusual items. The document is limited to the statutory notification of the share purchase.
Investor Verification Points
- Verify the total number of shares purchased (3,220) and the transaction price (£13.2433) against the London Stock Exchange records for September 29, 2022.
- Confirm the current shareholding balance of Sir Jonathan Symonds following this purchase.
- Note that this filing does not reflect the company's broader financial health or operational results for the period.